Lilly, Amylin Expand Byetta Deal: Vote Of Confidence Or Down Payment?

Lilly pays $125 million upfront as part of supply agreement for long-acting Byetta formulation.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet